Moreover, GLP-1R agonists stimulate ANGPTL8 production in human hepatocytes dose-dependently [50], and ANGPTL8 has been described as a novel vitamin D receptor target gene involved in nonalcoholic fatty liver pathogenesis [25]. This evidence concerns the gene VDR and non-alcoholic fatty liver.